Articles

• Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism

  W. D. Graf, A. S. Unis, C. M. Yates, S. Sulzbacher, M. B. Dinulos, R. M. Jack, K. A. Dugaw, M. N. Paddock, W. W. Parson

  • Abstract
  • Full Text
  • Full Text (PDF)
• LIS1 missense mutations cause milder lissencephaly phenotypes including a child with normal IQ

  Richard J. Leventer, Carlos Cardoso, David H. Ledbetter, William B. Dobyns

  • Abstract
  • Full Text
  • Full Text (PDF)
• Oculomotor abnormalities in attention deficit hyperactivity disorderA preliminary study

  S. H. Mostofsky, A. G. Lasker, L. E. Cutting, M. B. Denckla, D. S. Zee

  • Abstract
  • Full Text
  • Full Text (PDF)
• Sudden unexplained death in children with epilepsy

  Elizabeth J. Donner, Charles R. Smith, O. Carter Snead

  • Abstract
  • Full Text
  • Full Text (PDF)
• Increased driving accident frequency in Danish patients with epilepsy

  Svend Lings

  • Abstract
  • Full Text
  • Full Text (PDF)
• Early hormonal changes during valproate or carbamazepine treatmentA 3-month study

  J. Rättyä, A. J. Pakarinen, M. Knip, M. Repo–Outakoski, V. V. Myllylä, J. I.T. Isojärvi

  • Abstract
  • Full Text
  • Full Text (PDF)
• Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy [RETRACTED]

  Y. Sato, I. Kondo, S. Ishida, H. Motooka, K. Takayama, Y. Tomita, H. Maeda, K. Satoh

  • Abstract
  • Full Text (PDF)
• Decreased corticospinal excitability after subthreshold 1 Hz rTMS over lateral premotor cortex

  Willibald Gerschlager, Hartwig R. Siebner, John C. Rothwell

  • Abstract
  • Full Text
  • Full Text (PDF)
• Frequency of bowel movements and the future risk of Parkinson’s disease

  R. D. Abbott, H. Petrovitch, L. R. White, K. H. Masaki, C. M. Tanner, J. D. Curb, A. Grandinetti, P. L. Blanchette, J. S. Popper, G. W. Ross

  • Abstract
  • Full Text
  • Full Text (PDF)
• Time trends in the incidence of parkinsonism in Olmsted County, Minnesota

  W.A. Rocca, J.H. Bower, S.K. McDonnell, B.J. Peterson, D.M. Maraganore

  • Abstract
  • Full Text
  • Full Text (PDF)
• Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy

  I. Litvan, M. Phipps, V. L. Pharr, M. Hallett, J. Grafman, A. Salazar

  • Abstract
  • Full Text
  • Full Text (PDF)
• Predictors of good outcome after intravenous tPA for acute ischemic stroke

  A. M. Demchuk, D. Tanne, M. D. Hill, S. E. Kasner, S. Hanson, M. Grond, S. R. Levine, The Multicentre tPA Stroke Survey Group

  • Abstract
  • Full Text
  • Full Text (PDF)
• A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

  R. C. Mohs, R. S. Doody, J.C. Morris, J. R. Ieni, S. L. Rogers, C. A. Perdomo, R. D. Pratt, for the “312” Study Group

  • Abstract
  • Full Text
  • Full Text (PDF)
• A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

  B. Winblad, K. Engedal, H. Soininen, F. Verhey, G. Waldemar, A. Wimo, A.-L. Wetterholm, R. Zhang, A. Haglund, P. Subbiah, the Donepezil Nordic Study Group

  • Abstract
  • Full Text
  • Full Text (PDF)
• The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus

  H. Ainiala, J. Loukkola, J. Peltola, M. Korpela, A. Hietaharju

  • Abstract
  • Full Text
  • Full Text (PDF)
• Current management of ALSComparison of the ALS CARE Database and the AAN Practice Parameter

  W. G. Bradley, F. Anderson, M. Bromberg, L. Gutmann, Y. Harati, M. Ross, R. G. Miller, the ALS CARE Study Group

  • Abstract
  • Full Text
  • Full Text (PDF)
• Lamotrigine reduces painful diabetic neuropathyA randomized, controlled study

  E. Eisenberg, Y. Lurie, C. Braker, D. Daoud, A. Ishay

  • Abstract
  • Full Text
  • Full Text (PDF)